Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PRKX antisense RNA 1 (PRKX-AS1) is a long non-coding RNA gene that is transcribed from the opposite strand of the PRKX locus. As a natural antisense transcript, PRKX-AS1 may act in the regulation of PRKX gene expression, potentially via transcriptional interference, modulation of RNA stability, or chromatin modification, consistent with the known roles of other antisense lncRNAs. However, as of now, there are no peer-reviewed studies detailing tissue-specific expression, precise molecular mechanisms, or any direct association with human diseases or therapeutic interventions for PRKX-AS1.
Not applicable (as there are no drugs known to interact with PRKX-AS1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PRKX antisense RNA 1 (non-protein coding) (PRKX-AS1).